What is Wegovy? What are its side effects and what does it treat? - Panorama will look at the ‘game changing’ medication but ...

The weight-loss drug revolution is reshaping the health and wellness industry, forcing companies to adapt or face the same ...

In the first quarter of 2025, Ozempic and Wegovy’s maker, Novo Nordisk, spent more than $3 million on lobbying. So did Eli Lilly, which makes the weight-loss drug Zepbound and Mounjaro ...

PARIS (Reuters) - Jordan Bardella plans to be the French far-right National Rally's presidential candidate in 2027 if the party's leader Marine Le Pen remains barred from running, he told Le Parisien ...

NPH insulin is an older type of synthetic insulin that helps people with diabetes control their blood sugar. It’s typically injected once or twice a day at regular times and is designed to ...

Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out Penfill cartridges. This decision follows concerns about the discontinuation ...

In a move which could shake up the diabetes market, Novo Nordisk ... Insulatard, Insulin Detemir and Levemir and Xultophy — marketed mostly in the format of pre-filled disposable pen and ...

Medical Dialogues had earlier reported that Novo Nordisk is phasing out several pen-fill and cartridge-based insulin formulations — including its popular brand Mixtard, as part of its global portfolio ...

He abducts Reagan, puts her in the cage with Maddie. Joe tells Maddie to kill Reagan with her insulin pen, because it's the only way he can be assured that she won't go to the authorities and ...

Continuing our series highlighting recent presentations from Nursing in Practice 365 events, diabetes nursing specialist Debbie Hicks shares key points on the management of insulin therapy for nurses ...

Right: Medtronic’s MiniMed 780G. [Image courtesy of the companies] Medtronic (NYSE:MDT) announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable insulin ...

Thirty-seven-year-old Nupur Lalvani, who has been living with Type 1 diabetes since the age of eight, was dependent on insulin pens and had of late been a regular user of Novo Nordisk’s largest ...